Quantum
Home > Boards > US Listed > Medical - Equipment >

Cytosorbents Corporation (CTSO)

CTSO RSS Feed
Add CTSO Price Alert      Hide Sticky   Hide Intro
Moderator: orangecat, dah174174, caesare74
Search This Board: 
Last Post: 11/19/2018 1:52:38 AM - Followers: 211 - Board type: Free - Posts Today: 1

CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 45 countries around the world, as an extracorporeal cytokine adsorber designed to reduce the "cytokine storm" or "cytokine release syndrome" that could otherwise cause massive inflammation, organ failure and death in common critical illnesses. These are conditions where the risk of death is extremely high, yet no effective treatments exist. CytoSorb® is also being used during and after cardiac surgery to remove inflammatory mediators that can lead to post-operative complications, including multiple organ failure. CytoSorbents recently initiated its pivotal REFRESH (REduction in FREe Hemoglobin) 2 trial – a multi-center, randomized controlled, clinical trial intended to support U.S. regulatory approval of CytoSorb for use in a heart-lung machine during complex cardiac surgery to reduce organ injury. CytoSorb® has been used in more than 46,000 human treatments to date. 

CytoSorbents' purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its technologies have received non-dilutive grant, contract, and other funding of nearly $22 million from DARPA, the U.S. Army, the U.S. Department of Health and Human Services, the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), U.S. Special Operations Command (SOCOM) and others. The Company has numerous products under development based upon this unique blood purification technology, protected by 32 issued U.S. patents and multiple applications pending, including CytoSorb-XL™, HemoDefend™, VetResQ™, K+ontrol™, ContrastSorb, DrugSorb, and others. For more information, please visit the Company's websites at http://www.cytosorbents.com and http://www.cytosorb.com or follow us on Facebook and Twitter.

Quantum
CTSO
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTSO News: Current Report Filing (8-k) 11/07/2018 05:20:24 PM
CTSO News: Quarterly Report (10-q) 11/06/2018 04:41:27 PM
CTSO News: Statement of Changes in Beneficial Ownership (4) 08/31/2018 03:36:45 PM
CTSO News: Statement of Changes in Beneficial Ownership (4) 08/30/2018 04:03:43 PM
CTSO News: Statement of Changes in Beneficial Ownership (4) 08/30/2018 04:00:42 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#14095   Seemingly all of a sudden, the rumors/expectations of B52T38 11/19/18 01:52:38 AM
#14094   Do you think we could hear something from berthabluefish1 11/18/18 07:23:55 PM
#14093   Another good find tech.My Man. berthabluefish1 11/18/18 07:12:18 PM
#14092   Excellent link! Guess that (start-up company) Aferetica played caesare74 11/18/18 06:37:35 PM
#14091   Significant growth and sustainable move in pps will caesare74 11/18/18 06:21:33 PM
#14090   Order from Italy - two year supply techxen 11/18/18 06:09:55 PM
#14089   Can growth keep growing at such a good slappie 11/18/18 02:22:49 PM
#14088   # 304 andy55q 11/18/18 01:08:49 PM
#14087   Deloittes 2018 fast 500 Murph1953 11/18/18 12:56:20 PM
#14086   AGREE if good and break even achievement? Burnttoast247 11/17/18 04:11:27 PM
#14085   They may give us the preliminary 4Q and berthabluefish1 11/17/18 10:59:51 AM
#14084   Strong finish for a Friday albeit low volume Burnttoast247 11/16/18 05:05:11 PM
#14083   Fresenius and Terumo are potential partners.Heamonetics is the berthabluefish1 11/16/18 11:37:23 AM
#14082   https://nypost.com/2018/11/14/norovirus-outbreak-confirmed-at-california-wildfir Burnttoast247 11/16/18 10:52:55 AM
#14081   CAN’T INCREASE CTSO SALES FORCE IN A COUNTRY Burnttoast247 11/16/18 09:42:17 AM
#14080   Texcan, correct. CTSO has a great product pipeline caesare74 11/15/18 06:05:08 PM
#14079   Believe in the Filter, FDA, Wall Street, and slappie 11/15/18 04:41:31 PM
#14078   HEAR! HEAR! And a TOAST to Burnttoast! Happy Thanksgiving! raptorjockey 11/15/18 03:18:54 PM
#14077   STOP ALL THE *CHICKEN LITTLE* DR CHAN’s GONNA Burnttoast247 11/15/18 02:52:55 PM
#14076   Does he have full power for picking a Good Sport 11/15/18 02:30:24 PM
#14074   It would have to be a huge, under kegparty 11/15/18 01:36:58 PM
#14073   https://mailchi.mp/cytosorbents/upcoming-events-save-the-date-abstract-deadlines berthabluefish1 11/15/18 09:22:32 AM
#14072   CFO did comment on possible stock offering to ranchhand71 11/15/18 08:59:56 AM
#14071   Allopathic suppression care with no "cure" of Good Sport 11/14/18 10:42:44 PM
#14070   I am probably in the other 2 with orangecat 11/14/18 09:51:05 PM
#14069   Frustrating price drop, but it's not just CTSO. B52T38 11/14/18 09:23:21 PM
#14068   Couldn’t agree more re: your caution. I’m HadToHavit 11/14/18 08:52:29 PM
#14067   There was talk of $20 share price by slappie 11/14/18 08:17:51 PM
#14066   They might achieve better terms with the FDA coldterdinvestor 11/14/18 06:51:58 PM
#14065   And why a 400 patient trial for a eskay1954 11/14/18 06:38:10 PM
#14064   With all due respect to you, You should eskay1954 11/14/18 06:29:29 PM
#14063   Tks Fantomphan for the hint. 2020 was mentioned caesare74 11/14/18 06:13:48 PM
#14062   9 Bucks?.… I like you... Shakin my HadToHavit 11/14/18 05:14:39 PM
#14061   Bertha this is also consistent with what they techxen 11/14/18 04:05:13 PM
#14060   Kathleen also said HemoDefend will be our first berthabluefish1 11/14/18 02:37:15 PM
#14059   About 31:27 into the presentation yesterday From Kathleen berthabluefish1 11/14/18 02:35:26 PM
#14058   Yesterday you said FDA "2019/2020". Please explain the fantomphan 11/14/18 02:02:55 PM
#14057   "Hope to receive...approval....by 2021". WTF? kegparty 11/14/18 01:49:42 PM
#14056   Mentioned stock offering. This is falling knife pps slappie 11/14/18 12:58:14 PM
#14055   Correct Techxen. Key trigger for more sales here caesare74 11/14/18 12:41:33 PM
#14054   I mention, I am a bad guy. CFO slappie 11/14/18 12:37:38 PM
#14053   Caesare, do you interpret a more aggressive sales techxen 11/14/18 12:24:02 PM
#14052   Techxen, many tks. I'm fully with you about caesare74 11/14/18 12:08:36 PM
#14051   Re: "Cytosorb will probably need additional cash" techxen 11/14/18 11:38:18 AM
#14050   CytoSorbents Targets 4Q Profitability, US Trial Begun -- clints 11/14/18 11:16:20 AM
#14049   2 thumbs up !! Good Sport 11/14/18 11:11:08 AM
#14048   I still believe in selling more filters and clints 11/14/18 11:01:42 AM
#14047   very good link. As outlined a few times caesare74 11/14/18 10:52:32 AM
#14046   Case of the Week andy55q 11/14/18 09:03:09 AM
#14045   Easiest way is to go to most recent ranchhand71 11/13/18 08:48:30 PM
PostSubject